OBINUTUZUMAB

obinutuzumab 1 g/40 mL injection, 40 mL vial

OBINUTUZUMAB (11462G)

obinutuzumab 1 g/40 mL injection, 40 mL vial
11462G
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Stage II bulky or Stage III/IV follicular lymphoma
Treatment phase: Maintenance therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 1000 mg # of repeats: 5 DPMA: $4,390.47 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gazyva
(obinutuzumab 1 g/40 mL injection, 40 mL vial)